Aigen Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.44M | Buy |
+62,549
| New | +$3.44M | 0.47% | 30 |
|
|
2023
Q4 | – | Sell |
-8,691
| Closed | -$769K | – | 807 |
|
|
2023
Q3 | $769K | Buy |
8,691
+1,521
| +21% | +$135K | 0.14% | 228 |
|
|
2023
Q2 | $621K | Buy |
+7,170
| New | +$621K | 0.09% | 295 |
|
|
2022
Q2 | – | Sell |
-4,763
| Closed | -$367K | – | 538 |
|
|
2022
Q1 | $367K | Sell |
4,763
-497
| -9% | -$38.3K | 0.06% | 330 |
|
|
2021
Q4 | $446K | Buy |
+5,260
| New | +$446K | 0.03% | 670 |
|
|
2021
Q2 | – | Sell |
-7,317
| Closed | -$553K | – | 482 |
|
|
2021
Q1 | $553K | Buy |
+7,317
| New | +$553K | 0.07% | 275 |
|
|
2020
Q2 | – | Sell |
-1,071
| Closed | -$91K | – | 847 |
|
|
2020
Q1 | $91K | Buy |
+1,071
| New | +$91K | 0.01% | 879 |
|